Developing a Robust CRISPR-Cas9 Editing Process for a TIL Product
Time: 3:15 pm
day: Conference Day Two
Details:
- Developing a robust gene editing process to retain cell health and function
- Optimization of editing process to precisely deliver CRISPER components to TILs, maintaining sterility throughout the editing process, and minimizing contamination rises
- Enhancing reproducibility, ensuring the safety and efficacy of the editing TIL product
